Skip to main content
. 2016 Dec 8;158(3):505–515. doi: 10.1097/j.pain.0000000000000790

Table 1.

In vitro properties of the different investigated peptides, KGNOP1 (the hybrid, Dmt-D-Arg-Aba-β-Ala-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2), KGOP1 (the opioid receptor agonist, Dmt-D-Arg-Aba-β-Ala-NH2), and KGNOP3 (the nociceptin receptor antagonist, Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2).

graphic file with name jop-158-505-g001.jpg

HHS Vulnerability Disclosure